Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine, NYU Winthrop Hospital, Mineola, NY, USA.
Pain Med. 2021 Jun 4;22(6):1435-1440. doi: 10.1093/pm/pnab072.
Herbs and natural products are increasingly used by cancer patients for pain management, but few studies have examined their integration within conventional cancer care. This study describes the characteristics, experiences, and perspectives of cancer patients who were prescribed an herbal topical analgesic for pain management.
Program evaluation of a pilot herbal dispensary at a National Cancer Institute-designated comprehensive cancer center.
Cancer patients who were prescribed the Tibetree Pain-Relieving Plaster (PRP) by an integrative medicine physician.
Sociodemographic and clinical characteristics of patients were abstracted from medical records. Semistructured phone interviews were conducted 1-2 weeks after PRP prescription to evaluate patient experiences with using PRP for pain. Interviews were analyzed through thematic content analysis.
From February 2019 to February 2020, 50 patients were prescribed PRP. Median age (range) was 63 years (21-86), 37 patients (74%) were female, 14 (28%) were non-White, and 38 (76%) were using oral analgesics. During interviews, the majority of patients reported that the PRP improved pain and health-related outcomes, was convenient to use, and addressed pain management needs that were not fulfilled by oral analgesics. However, a few patients described adverse experiences with PRP, including skin irritation.
Understanding patient experiences and perspectives is a critical step toward evidence-based integration of herbs and natural products into cancer pain management. Findings from this program evaluation will inform the design of a randomized clinical trial on the efficacy and safety of PRP for pain in patients with cancer.
癌症患者越来越多地使用草药和天然产品来缓解疼痛,但很少有研究调查这些产品在常规癌症治疗中的整合情况。本研究描述了接受开处草药局部止痛贴(西藏树止痛膏,PRP)处方的癌症患者的特征、经历和观点。
国家癌症研究所指定的综合癌症中心的试点草药药房的项目评估。
接受整合医学医师开处西藏树止痛膏(PRP)的癌症患者。
从病历中提取患者的社会人口统计学和临床特征。在 PRP 处方后 1-2 周,通过半结构化电话访谈评估患者使用 PRP 缓解疼痛的经历。通过主题内容分析对访谈进行分析。
从 2019 年 2 月至 2020 年 2 月,50 名患者被开处 PRP。中位数(范围)年龄为 63 岁(21-86 岁),37 名患者(74%)为女性,14 名(28%)为非白人,38 名(76%)正在服用口服止痛药。在访谈中,大多数患者报告 PRP 改善了疼痛和健康相关结果,使用方便,满足了口服止痛药无法满足的疼痛管理需求。然而,少数患者描述了 PRP 的不良反应,包括皮肤刺激。
了解患者的经历和观点是将草药和天然产品纳入癌症疼痛管理的循证整合的关键步骤。本项目评估的结果将为 PRP 治疗癌症患者疼痛的疗效和安全性的随机临床试验设计提供信息。